Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	MOK CDC42BPA TRIO MARK1 CDK19 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	4.22e-07	363	167	15	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	MOK CDC42BPA TRIO MARK1 CDK19 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 MARK4 TAOK1 MAP2K3 CDK2	1.12e-06	446	167	16	GO:0004674
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	MOK CDK19 CDKL4 CDK10 CDK2	4.64e-06	30	167	5	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	MOK CDK19 CDKL4 CDK10 CDK2	4.64e-06	30	167	5	GO:0097472
GeneOntologyMolecularFunction	protein kinase activity	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 MARK4 TAOK1 MAP2K3 CDK2	1.20e-05	600	167	17	GO:0004672
GeneOntologyMolecularFunction	ATP-dependent activity	KIF6 ATP7A ATP7B DNAH10 MYO7B KIF26B MYO1H MLH3 ABCA6 CHD5 DNAH17 MYO1F SHOC1 MACF1 DHX32 HSPA2 RAD54L	1.62e-05	614	167	17	GO:0140657
GeneOntologyMolecularFunction	kinase activity	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 TRRAP CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 PI4KB MARK4 TAOK1 MAP2K3 CDK2	2.25e-05	764	167	19	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 PI4KB MARK4 TAOK1 MAP2K3 CDK2	2.86e-05	709	167	18	GO:0016773
GeneOntologyMolecularFunction	tau-protein kinase activity	MARK1 TAOK2 MARK4 TAOK1	3.07e-05	22	167	4	GO:0050321
GeneOntologyMolecularFunction	tau protein binding	MARK1 TAOK2 MARK4 TAOK1 HSPA2	4.00e-05	46	167	5	GO:0048156
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF6 DNAH10 MYO7B KIF26B MYO1H DNAH17 MYO1F	6.11e-05	118	167	7	GO:0003774
GeneOntologyMolecularFunction	P-type divalent copper transporter activity	ATP7A ATP7B	6.95e-05	2	167	2	GO:0043682
GeneOntologyMolecularFunction	P-type monovalent copper transporter activity	ATP7A ATP7B	6.95e-05	2	167	2	GO:0140581
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CRPPA TRRAP CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 PI4KB MARK4 TAOK1 MAP2K3 CDK2	1.16e-04	938	167	20	GO:0016772
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF6 ATP7A ATP7B DNAH10 MLH3 ABCA6 CHD5 SHOC1 MACF1 DHX32 HSPA2 RAD54L	3.48e-04	441	167	12	GO:0016887
GeneOntologyMolecularFunction	protein serine/threonine kinase activator activity	ALS2 CCNYL3 TAOK2 TAOK1 CAB39L	4.97e-04	78	167	5	GO:0043539
GeneOntologyMolecularFunction	testosterone 6-beta-hydroxylase activity	CYP3A7 CYP3A5	6.84e-04	5	167	2	GO:0050649
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE3 SYNE2	6.84e-04	5	167	2	GO:0140444
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RAB23 KIF6 ATP7A ATP7B DNAH10 SEPTIN2 MLH3 ABCA6 CHD5 SHOC1 MACF1 RASL11B DHX32 HSPA2 ARL14 RAD54L	8.10e-04	775	167	16	GO:0017111
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF6 VEZT MYO7B KIF26B MARK1 MYO1H SPTAN1 CEP290 TAOK2 SYNE3 MED28 SYNE2 MARK4 MYO1F DIAPH2 MACF1 TAOK1 DMD HSPA2 UTRN	8.86e-04	1099	167	20	GO:0008092
GeneOntologyMolecularFunction	pyrophosphatase activity	RAB23 KIF6 ATP7A ATP7B DNAH10 SEPTIN2 MLH3 ABCA6 CHD5 SHOC1 MACF1 RASL11B DHX32 HSPA2 ARL14 RAD54L	1.84e-03	839	167	16	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RAB23 KIF6 ATP7A ATP7B DNAH10 SEPTIN2 MLH3 ABCA6 CHD5 SHOC1 MACF1 RASL11B DHX32 HSPA2 ARL14 RAD54L	1.86e-03	840	167	16	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RAB23 KIF6 ATP7A ATP7B DNAH10 SEPTIN2 MLH3 ABCA6 CHD5 SHOC1 MACF1 RASL11B DHX32 HSPA2 ARL14 RAD54L	1.86e-03	840	167	16	GO:0016818
GeneOntologyMolecularFunction	copper ion transmembrane transporter activity	ATP7A ATP7B	1.88e-03	8	167	2	GO:0005375
GeneOntologyMolecularFunction	estrogen 2-hydroxylase activity	CYP3A7 CYP3A5	1.88e-03	8	167	2	GO:0101021
GeneOntologyMolecularFunction	actin binding	MYO7B MYO1H SPTAN1 SYNE3 MED28 SYNE2 MYO1F DIAPH2 MACF1 DMD UTRN	2.38e-03	479	167	11	GO:0003779
GeneOntologyCellularComponent	male germ cell nucleus	KIF6 RGS22 MLH3 HSPA2 STAG3 CDK2	6.16e-05	86	165	6	GO:0001673
GeneOntologyCellularComponent	nuclear outer membrane	NUCB2 ITPR3 SYNE3 SYNE2	2.74e-04	40	165	4	GO:0005640
GeneOntologyCellularComponent	germ cell nucleus	KIF6 RGS22 MLH3 HSPA2 STAG3 CDK2	2.78e-04	113	165	6	GO:0043073
MousePheno	male infertility	TDRD5 KIF6 ATP7A DNAH10 TOPAZ1 NUP210L CYP19A1 CEP290 TDRD7 IVL MLH3 CHD5 DNAH17 DCAF17 DMD HERC1 SPAG17 GPAT2 HSPA2 STAG3 AP3D1 HYDIN WDR62 CDK2 UTP14C	1.05e-06	944	127	25	MP:0001925
MousePheno	infertility	TDRD5 KIF6 ATP7A DNAH10 TOPAZ1 NUP210L CYP19A1 CEP290 NEK7 TDRD7 IVL MLH3 CHD5 DNAH17 ARID5B DCAF17 EFR3B DMD HERC1 SPAG17 GPAT2 HSPA2 STAG3 AP3D1 HYDIN WDR62 CDK2 UTP14C	2.15e-06	1188	127	28	MP:0001924
MousePheno	abnormal male reproductive system physiology	TDRD5 KIF6 ATP7A DNAH10 TOPAZ1 NUP210L CYP19A1 CEP290 TDRD7 IVL MLH3 CHD5 DNAH17 ARID5B DCAF17 SHOC1 DMD HERC1 SPAG17 GPAT2 HSPA2 STAG3 AP3D1 HYDIN WDR62 CDK2 UTP14C	5.00e-05	1329	127	27	MP:0003698
MousePheno	abnormal male meiosis	TDRD5 TOPAZ1 MLH3 DCAF17 SHOC1 HSPA2 STAG3 WDR62 CDK2	7.14e-05	195	127	9	MP:0005169
MousePheno	abnormal kidney copper level	ATP7A ATP7B	8.19e-05	2	127	2	MP:0010242
MousePheno	increased kidney copper level	ATP7A ATP7B	8.19e-05	2	127	2	MP:0010243
MousePheno	increased brain copper level	ATP7A ATP7B	8.19e-05	2	127	2	MP:0011214
MousePheno	abnormal cerebral aqueduct morphology	SPTAN1 UCHL5 KDM2B HYDIN	9.70e-05	27	127	4	MP:0005537
MousePheno	abnormal sperm number	DNAH10 TOPAZ1 NUP210L CYP19A1 MLH3 CHD5 DNAH17 DCAF17 SHOC1 KDM2B SPAG17 GPAT2 STAG3 WDR62 CDK2 UTP14C	1.67e-04	624	127	16	MP:0002673
MousePheno	abnormal spermatogenesis	TDRD5 DNAH10 TOPAZ1 NUP210L CYP19A1 TDRD7 MLH3 CHD5 DNAH17 ARID5B DCAF17 SHOC1 KDM2B SPAG17 GPAT2 HSPA2 STAG3 WDR62 CDK2 UTP14C	1.98e-04	910	127	20	MP:0001156
MousePheno	decreased male germ cell number	DNAH10 TOPAZ1 NUP210L CYP19A1 MLH3 CHD5 DNAH17 DCAF17 SHOC1 KDM2B SPAG17 GPAT2 STAG3 WDR62 CDK2 UTP14C	2.22e-04	640	127	16	MP:0004901
MousePheno	decreased liver copper level	ATP7A ATP7B	2.44e-04	3	127	2	MP:0003067
MousePheno	decreased circulating copper level	ATP7A ATP7B	2.44e-04	3	127	2	MP:0006349
Domain	Spectrin	TRIO SPTAN1 SYNE3 SYNE2 MACF1 DMD UTRN	5.94e-10	23	158	7	PF00435
Domain	Spectrin_repeat	TRIO SPTAN1 SYNE3 SYNE2 MACF1 DMD UTRN	3.62e-09	29	158	7	IPR002017
Domain	Kinase-like_dom	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 TRRAP CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 PI4KB MARK4 MACF1 TAOK1 DMD MAP2K3 CDK2	6.37e-09	542	158	21	IPR011009
Domain	SPEC	TRIO SPTAN1 SYNE3 SYNE2 MACF1 DMD UTRN	7.65e-09	32	158	7	SM00150
Domain	Spectrin/alpha-actinin	TRIO SPTAN1 SYNE3 SYNE2 MACF1 DMD UTRN	7.65e-09	32	158	7	IPR018159
Domain	Pkinase	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 MARK4 TAOK1 MAP2K3 CDK2	2.57e-08	381	158	17	PF00069
Domain	S_TKc	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	6.88e-08	359	158	16	SM00220
Domain	Ser/Thr_kinase_AS	MOK CDC42BPA TRIO MARK1 CDK19 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	3.84e-07	357	158	15	IPR008271
Domain	PROTEIN_KINASE_ST	MOK CDC42BPA TRIO MARK1 CDK19 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	4.58e-07	362	158	15	PS00108
Domain	Prot_kinase_dom	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 MARK4 TAOK1 MAP2K3 CDK2	8.88e-07	489	158	17	IPR000719
Domain	PROTEIN_KINASE_DOM	MOK CDC42BPA TRIO MARK1 CDK19 SCYL3 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 NRBP2 MARK4 TAOK1 MAP2K3 CDK2	9.94e-07	493	158	17	PS50011
Domain	ARM-type_fold	IPO5 NOC2L SCYL3 CUL7 TRRAP UNC45B NBEAL2 DIAPH2 EFR3B CAB39L STAG3 AP3D1 IPO11	6.42e-06	339	158	13	IPR016024
Domain	PROTEIN_KINASE_ATP	MOK CDC42BPA TRIO MARK1 CDK19 NEK7 CDKL4 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	8.50e-06	459	158	15	PS00107
Domain	ARM-like	IPO5 SCYL3 CUL7 TRRAP UNC45B NBEAL2 EFR3B CAB39L STAG3 AP3D1 IPO11	1.94e-05	270	158	11	IPR011989
Domain	-	IPO5 SCYL3 CUL7 TRRAP UNC45B EFR3B CAB39L STAG3 AP3D1 IPO11	1.99e-05	222	158	10	1.25.10.10
Domain	Protein_kinase_ATP_BS	MOK CDC42BPA MARK1 CDK19 NEK7 CDK10 TAOK2 TAOK3 CAMKK2 MARK4 TAOK1 MAP2K3 CDK2	2.10e-05	379	158	13	IPR017441
Domain	ACTININ_2	SYNE2 MACF1 DMD UTRN	3.85e-05	23	158	4	PS00020
Domain	ACTININ_1	SYNE2 MACF1 DMD UTRN	3.85e-05	23	158	4	PS00019
Domain	Actinin_actin-bd_CS	SYNE2 MACF1 DMD UTRN	3.85e-05	23	158	4	IPR001589
Domain	P-typ_ATPase_IB	ATP7A ATP7B	7.11e-05	2	158	2	IPR027256
Domain	Dystrophin	DMD UTRN	7.11e-05	2	158	2	IPR016344
Domain	Glypican-3	GPC3 GPC5	7.11e-05	2	158	2	IPR015501
Domain	HMA_Cu_ion-bd	ATP7A ATP7B	7.11e-05	2	158	2	IPR006122
Domain	UBA	MARK1 UBQLN4 VPS13D MARK4	1.14e-04	30	158	4	SM00165
Domain	OST-HTH/LOTUS_dom	TDRD5 TDRD7	2.12e-04	3	158	2	IPR025605
Domain	OST-HTH	TDRD5 TDRD7	2.12e-04	3	158	2	PF12872
Domain	HTH_OST	TDRD5 TDRD7	2.12e-04	3	158	2	PS51644
Domain	Heavy-metal-associated_CS	ATP7A ATP7B	2.12e-04	3	158	2	IPR017969
Domain	UBA	MARK1 UBQLN4 VPS13D MARK4	2.35e-04	36	158	4	PF00627
Domain	-	CEP95 SYNE2 MACF1 DMD UTRN	3.38e-04	71	158	5	1.10.418.10
Domain	KASH	SYNE3 SYNE2	4.22e-04	4	158	2	IPR012315
Domain	HMA	ATP7A ATP7B	4.22e-04	4	158	2	PF00403
Domain	MARK/par1	MARK1 MARK4	4.22e-04	4	158	2	IPR033624
Domain	KASH	SYNE3 SYNE2	4.22e-04	4	158	2	PS51049
Domain	KASH	SYNE3 SYNE2	4.22e-04	4	158	2	SM01249
Domain	KASH	SYNE3 SYNE2	4.22e-04	4	158	2	PF10541
Domain	HMA_2	ATP7A ATP7B	4.22e-04	4	158	2	PS50846
Domain	HMA_1	ATP7A ATP7B	4.22e-04	4	158	2	PS01047
Domain	CH-domain	CEP95 SYNE2 MACF1 DMD UTRN	4.36e-04	75	158	5	IPR001715
Domain	UBA	MARK1 UBQLN4 VPS13D MARK4	5.14e-04	44	158	4	IPR015940
Domain	UBA	MARK1 UBQLN4 VPS13D MARK4	6.63e-04	47	158	4	PS50030
Domain	KA1	MARK1 MARK4	6.99e-04	5	158	2	PF02149
Domain	Cyt_P450_E_grp-II	CYP3A7 CYP3A5	6.99e-04	5	158	2	IPR002402
Domain	KA1_dom	MARK1 MARK4	6.99e-04	5	158	2	IPR001772
Domain	KA1	MARK1 MARK4	6.99e-04	5	158	2	PS50032
Domain	-	MARK1 MARK4	6.99e-04	5	158	2	3.30.310.80
Domain	Cyt_P450_E_CYP3A	CYP3A7 CYP3A5	1.04e-03	6	158	2	IPR008072
Domain	GLYPICAN	GPC3 GPC5	1.04e-03	6	158	2	PS01207
Domain	Glypican	GPC3 GPC5	1.04e-03	6	158	2	IPR001863
Domain	Glypican_CS	GPC3 GPC5	1.04e-03	6	158	2	IPR019803
Domain	EF-hand_dom_typ1	DMD UTRN	1.04e-03	6	158	2	IPR015153
Domain	EF-hand_dom_typ2	DMD UTRN	1.04e-03	6	158	2	IPR015154
Domain	Glypican	GPC3 GPC5	1.04e-03	6	158	2	PF01153
Domain	EF-hand_2	DMD UTRN	1.04e-03	6	158	2	PF09068
Domain	EF-hand_3	DMD UTRN	1.04e-03	6	158	2	PF09069
Domain	KA1/Ssp2_C	MARK1 MARK4	1.45e-03	7	158	2	IPR028375
Domain	HMA_dom	ATP7A ATP7B	1.45e-03	7	158	2	IPR006121
Domain	TUDOR	TDRD5 ARID4B TDRD7	1.50e-03	27	158	3	SM00333
Domain	Reticulon	RTN1 PRR18	1.93e-03	8	158	2	IPR003388
Domain	DH_1	TRIO ARHGEF12 ALS2 ARHGEF40	1.99e-03	63	158	4	PS00741
Domain	Tudor	TDRD5 ARID4B TDRD7	2.04e-03	30	158	3	IPR002999
Domain	CH	SYNE2 MACF1 DMD UTRN	2.24e-03	65	158	4	SM00033
Domain	RhoGEF	TRIO ARHGEF12 ALS2 ARHGEF40	2.93e-03	70	158	4	PF00621
Domain	CH	SYNE2 MACF1 DMD UTRN	2.93e-03	70	158	4	PF00307
Domain	HEAT_REPEAT	IPO5 SCYL3 AP3D1 IPO11	2.93e-03	70	158	4	PS50077
Domain	DH_2	TRIO ARHGEF12 ALS2 ARHGEF40	2.93e-03	70	158	4	PS50010
Domain	-	TRIO ARHGEF12 ALS2 ARHGEF40	3.09e-03	71	158	4	1.20.900.10
Domain	DH-domain	TRIO ARHGEF12 ALS2 ARHGEF40	3.09e-03	71	158	4	IPR000219
Domain	CH	SYNE2 MACF1 DMD UTRN	3.41e-03	73	158	4	PS50021
Domain	-	RARS1 IARS1	3.72e-03	11	158	2	1.10.730.10
Domain	GDS_CDC24_CS	TRIO ARHGEF12 ALS2	4.34e-03	39	158	3	IPR001331
Domain	L27	MPP3 MPDZ	5.22e-03	13	158	2	SM00569
Domain	L27	MPP3 MPDZ	5.22e-03	13	158	2	PS51022
Domain	L27_dom	MPP3 MPDZ	5.22e-03	13	158	2	IPR004172
Domain	P-loop_NTPase	RAB23 MPP3 KIF6 DNAH10 MYO7B KIF26B SEPTIN2 ABCA6 CHD5 MYO1F RASL11B DHX32 HYDIN ARL14 RAD54L	5.60e-03	848	158	15	IPR027417
Domain	IMPORTIN_B_NT	IPO5 IPO11	6.05e-03	14	158	2	PS50166
Domain	TUDOR	TDRD5 TDRD7	6.05e-03	14	158	2	PF00567
Domain	Cyt_P450_E_grp-I	CYP3A7 CYP3A5 CYP19A1	6.50e-03	45	158	3	IPR002401
Domain	-	ARID4B ARID5B	6.95e-03	15	158	2	1.10.150.60
Domain	BRIGHT	ARID4B ARID5B	6.95e-03	15	158	2	SM00501
Domain	ARID_dom	ARID4B ARID5B	6.95e-03	15	158	2	IPR001606
Domain	ARID	ARID4B ARID5B	6.95e-03	15	158	2	PS51011
Domain	ARID	ARID4B ARID5B	6.95e-03	15	158	2	PF01388
Domain	tRNAsynth_Ia_anticodon-bd	RARS1 IARS1	6.95e-03	15	158	2	IPR009080
Domain	-	TRRAP PI4KB	7.89e-03	16	158	2	1.10.1070.11
Domain	PI3Kc	TRRAP PI4KB	7.89e-03	16	158	2	SM00146
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO KIF26B ARHGEF12 MPDZ ZDBF2 RTN1 VPS13D MACF1 AKAP11 EIF3A CRYBG3 UTRN WDR62	3.43e-11	209	168	13	36779422
Pubmed	Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38.	TAOK2 TAOK3 TAOK1 MAP2K3	2.62e-09	5	168	4	13679851
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TCF12 ATP7B ARID4B UACA ADAMTS1 VEZT BIRC2 CUL7 TRRAP ADH4 ARHGEF40 MLH3 ZNF592 CBY2 CHD5 BRPF1 MARK4 XRN1 MACF1 CRYBG3 WDR62 NOVA2	2.52e-08	1116	168	22	31753913
Pubmed	Network organization of the human autophagy system.	IPO5 ATG16L1 NEK7 BIRC2 ECHS1 KHSRP CAMKK2 PI4KB DCAF17 TAOK1 CAB39L EIF3A UTRN WDR62	3.22e-08	437	168	14	20562859
Pubmed	Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades.	TAOK2 TAOK1 MAP2K3	1.11e-07	3	168	3	9786855
Pubmed	TAO kinases mediate activation of p38 in response to DNA damage.	TAOK2 TAOK3 TAOK1	1.11e-07	3	168	3	17396146
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDC42BPA TRIO KIF26B SPTAN1 HJURP MPDZ ALS2 VPS13D CEP95 PI4KB SYNE2 MARK4 XRN1 MACF1 AKAP11 CRYBG3 UTRN WDR62	2.19e-07	861	168	18	36931259
Pubmed	Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain.	TAOK2 TAOK1 MAP2K3	4.41e-07	4	168	3	10497253
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CDC42BPA TRIO VEZT SPTAN1 CEP290 SCYL3 NAA50 CUL7 ITPR3 SUPT5H UCHL5 SYNE2 EFR3B PHLPP1 CRYBG3 DMD HERC1 HSPA2 UTRN	8.65e-07	1049	168	19	27880917
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	RARS1 TRIO MPDZ BIRC2 CUL7 TRRAP SUPT5H UCHL5 XRN1	1.00e-06	212	168	9	33853758
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	TOPAZ1 TRRAP VPS13D TAOK3 HP ZNF592 NBEAL2 DIAPH2 TAOK1 HERC1 AP3D1 HYDIN IPO11	1.01e-06	497	168	13	36774506
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RAB23 ATP7A ATP7B CDC42BPA VEZT SCYL3 RTN1 ITPR3 VPS13D PI4KB SYNE2 DIAPH2 AKAP11	1.18e-06	504	168	13	34432599
Pubmed	Streamlined analysis schema for high-throughput identification of endogenous protein complexes.	CDK19 MED14 ZNF592 MED28 INTS9 MED23	1.28e-06	71	168	6	20133760
Pubmed	Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.	IPO5 RARS1 TRIO CARHSP1 IARS1 ECHS1 TRRAP SEPTIN2 AP3D1	1.64e-06	225	168	9	31478661
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CDC42BPA UACA TRIO MARK1 NEK7 BIRC2 CUL7 TRRAP CDK10 KHSRP TAOK3 CAMKK2 ARHGEF40 AKAP11 MAP2K3 UTRN CDK2	2.24e-06	910	168	17	36736316
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP7A CDC42BPA UACA VEZT NOC2L SPTAN1 NUCB2 MRPL58 MPDZ ECHS1 ITPR3 MRPS10 CAMKK2 SYNE3 SYNE2 EFR3B MACF1 AKAP11 CRYBG3 HSPA2 AP3D1 WDR62	3.18e-06	1487	168	22	33957083
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DNAH10 SPTAN1 ARHGEF12 TRRAP SYNE2 EIF3A DMD HSPA2	3.84e-06	187	168	8	26460568
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	HDAC11 CYP19A1 NUCB2 ITPR3 SEPTIN2 MYO1F GPC5 SPAG17	5.85e-06	198	168	8	20881960
Pubmed	Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.	DMD HSPA2 UTRN	6.09e-06	8	168	3	22495301
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	IPO5 CDC42BPA UACA TRIO ITPR3 ARHGEF40 XRN1 AP3D1	6.77e-06	202	168	8	33005030
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	IPO5 IARS1 SPTAN1 KCNAB2 TRRAP SEPTIN2 TAOK3 SUPT5H EIF3A IPO11	7.43e-06	344	168	10	30333137
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	IPO5 TRIO SPTAN1 CAMKK2 MACF1 DMD UTRN	9.32e-06	151	168	7	17043677
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	IPO5 RARS1 IARS1 SPTAN1 MCTS1 ECHS1 SEPTIN2 BRPF1 MACF1 EIF3A SPAG17 HSPA2 UTRN AP3D1 HYDIN	9.65e-06	807	168	15	30575818
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	IPO5 TCF12 ZDBF2 CUL7 SUPT5H ARID5B MACF1 INTS9 AKAP11	1.02e-05	282	168	9	23667531
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CDC42BPA RARS1 TRIO VEZT MARK1 IARS1 SPTAN1 KCNAB2 ZDBF2 ECHS1 RTN1 KHSRP TAOK2 ISOC2 XRN1 MACF1 CRYBG3 HSPA2	1.11e-05	1139	168	18	36417873
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	RARS1 HJURP KHSRP ISOC2 CRYBG3 HSPA2 WDR62	1.15e-05	156	168	7	32850835
Pubmed	Impact of lactobacilli on orally acquired listeriosis.	CYP3A5 TRDN GPC3 HMCN1 HP MYO1F CA5B	1.47e-05	162	168	7	23012479
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CDK19 ALS2 CAMKK2 CHD5 SYNE2 PHLPP1 MACF1 AKAP11	1.48e-05	225	168	8	12168954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	RAB23 ATG16L1 RARS1 KIF26B TOPAZ1 IARS1 CEP290 LRRC70 ZNF592 CEP95 ARID5B EIF3A LONRF2 UTRN	1.50e-05	736	168	14	29676528
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 NOC2L SPTAN1 CUL7 TRRAP KHSRP ITPR3 SUPT5H SYNE2 XRN1 MACF1 HSPA2 UTRN	1.90e-05	653	168	13	22586326
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	IPO5 IARS1 SPTAN1 TRRAP TRDN VPS13D DIAPH2 EIF3A	2.03e-05	235	168	8	30258100
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ARID4B TRIO SPTAN1 MCTS1 ARHGEF12 MPDZ ITIH3 KHSRP SEPTIN2 MCTS2 AP3D1	2.17e-05	475	168	11	31040226
Pubmed	Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.	DMD UTRN	2.32e-05	2	168	2	10525423
Pubmed	Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy.	ATP7A ATP7B	2.32e-05	2	168	2	29394468
Pubmed	Expression of the Menkes gene homologue in mouse tissues lack of effect of copper on the mRNA levels.	ATP7A ATP7B	2.32e-05	2	168	2	8082762
Pubmed	In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.	DMD UTRN	2.32e-05	2	168	2	28790199
Pubmed	Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.	DMD UTRN	2.32e-05	2	168	2	25859846
Pubmed	G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.	DMD UTRN	2.32e-05	2	168	2	7731967
Pubmed	Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue.	DMD UTRN	2.32e-05	2	168	2	16710609
Pubmed	Solution structures of the actuator domain of ATP7A and ATP7B, the Menkes and Wilson disease proteins.	ATP7A ATP7B	2.32e-05	2	168	2	19645496
Pubmed	Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.	DMD UTRN	2.32e-05	2	168	2	30672725
Pubmed	Differential intracellular localisation of the Menkes and Wilson copper transporting ATPases in the third trimester human placenta.	ATP7A ATP7B	2.32e-05	2	168	2	21115196
Pubmed	Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.	DMD UTRN	2.32e-05	2	168	2	7962191
Pubmed	Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?	DMD UTRN	2.32e-05	2	168	2	8021701
Pubmed	Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.	DMD UTRN	2.32e-05	2	168	2	26974331
Pubmed	Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.	DMD UTRN	2.32e-05	2	168	2	28453658
Pubmed	A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.	DMD UTRN	2.32e-05	2	168	2	11801396
Pubmed	Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.	DMD UTRN	2.32e-05	2	168	2	7987307
Pubmed	Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B.	ATP7A ATP7B	2.32e-05	2	168	2	28164426
Pubmed	Comparative analysis of the human dystrophin and utrophin gene structures.	DMD UTRN	2.32e-05	2	168	2	11861579
Pubmed	Distinct mechanical properties in homologous spectrin-like repeats of utrophin.	DMD UTRN	2.32e-05	2	168	2	30914715
Pubmed	Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.	DMD UTRN	2.32e-05	2	168	2	22284942
Pubmed	Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.	DMD UTRN	2.32e-05	2	168	2	17889902
Pubmed	Biochemical basis of regulation of human copper-transporting ATPases.	ATP7A ATP7B	2.32e-05	2	168	2	17562324
Pubmed	Genes regulating copper metabolism.	ATP7A ATP7B	2.32e-05	2	168	2	9823011
Pubmed	Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression.	DMD UTRN	2.32e-05	2	168	2	35557546
Pubmed	Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.	DMD UTRN	2.32e-05	2	168	2	37626761
Pubmed	Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin.	DMD UTRN	2.32e-05	2	168	2	15565469
Pubmed	Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.	ATP7A ATP7B	2.32e-05	2	168	2	17717039
Pubmed	The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.	DMD UTRN	2.32e-05	2	168	2	26516677
Pubmed	Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.	DMD UTRN	2.32e-05	2	168	2	22209498
Pubmed	A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET.	DMD UTRN	2.32e-05	2	168	2	37108685
Pubmed	Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.	DMD UTRN	2.32e-05	2	168	2	10694796
Pubmed	Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients.	ATP7A ATP7B	2.32e-05	2	168	2	20045993
Pubmed	Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B.	ATP7A ATP7B	2.32e-05	2	168	2	38032054
Pubmed	Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.	DMD UTRN	2.32e-05	2	168	2	24337461
Pubmed	Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.	DMD UTRN	2.32e-05	2	168	2	11297940
Pubmed	Molecular features of copper binding proteins involved in copper homeostasis.	ATP7A ATP7B	2.32e-05	2	168	2	27896900
Pubmed	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.	DMD UTRN	2.32e-05	2	168	2	22388933
Pubmed	Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.	DMD UTRN	2.32e-05	2	168	2	25642938
Pubmed	Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.	DMD UTRN	2.32e-05	2	168	2	15703201
Pubmed	Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.	DMD UTRN	2.32e-05	2	168	2	25941878
Pubmed	Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link.	DMD UTRN	2.32e-05	2	168	2	9297964
Pubmed	SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.	DMD UTRN	2.32e-05	2	168	2	25652448
Pubmed	Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.	DMD UTRN	2.32e-05	2	168	2	28785010
Pubmed	CYP3A gene expression in human gut epithelium.	CYP3A7 CYP3A5	2.32e-05	2	168	2	7894497
Pubmed	Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.	DMD UTRN	2.32e-05	2	168	2	16307000
Pubmed	Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.	DMD UTRN	2.32e-05	2	168	2	21949353
Pubmed	Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.	DMD UTRN	2.32e-05	2	168	2	23097179
Pubmed	The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.	DMD UTRN	2.32e-05	2	168	2	15501597
Pubmed	Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.	DMD UTRN	2.32e-05	2	168	2	11257121
Pubmed	Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.	DMD UTRN	2.32e-05	2	168	2	18973234
Pubmed	Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.	DMD UTRN	2.32e-05	2	168	2	27881412
Pubmed	CYP3A genes and the association between prenatal methylmercury exposure and neurodevelopment.	CYP3A7 CYP3A5	2.32e-05	2	168	2	28500872
Pubmed	Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.	DMD UTRN	2.32e-05	2	168	2	20625423
Pubmed	Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.	DMD UTRN	2.32e-05	2	168	2	29065908
Pubmed	Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.	DMD UTRN	2.32e-05	2	168	2	31039133
Pubmed	Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A.	ATP7A ATP7B	2.32e-05	2	168	2	28271598
Pubmed	Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain.	DMD UTRN	2.32e-05	2	168	2	11796130
Pubmed	Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.	DMD UTRN	2.32e-05	2	168	2	8159184
Pubmed	Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.	DMD UTRN	2.32e-05	2	168	2	10679963
Pubmed	TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.	DMD UTRN	2.32e-05	2	168	2	21565990
Pubmed	Generation and characterization of transgenic mice with the full-length human DMD gene.	DMD UTRN	2.32e-05	2	168	2	18083704
Pubmed	Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles.	DMD UTRN	2.32e-05	2	168	2	8186702
Pubmed	Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.	DMD UTRN	2.32e-05	2	168	2	25940966
Pubmed	Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.	DMD UTRN	2.32e-05	2	168	2	22266080
Pubmed	Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.	DMD UTRN	2.32e-05	2	168	2	17300937
Pubmed	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	DMD UTRN	2.32e-05	2	168	2	21768542
Pubmed	Social stress is lethal in the mdx model of Duchenne muscular dystrophy.	DMD UTRN	2.32e-05	2	168	2	32192914
Pubmed	[Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].	ATP7A ATP7B	2.32e-05	2	168	2	21117320
Interaction	CDC42 interactions	RAB23 IPO5 CDC42BPA RARS1 TRIO CARHSP1 VEZT KIF26B IARS1 SPTAN1 ARHGEF12 BIRC2 ECHS1 TRRAP ITPR3 SEPTIN2 TAOK2 TAOK3 ARHGEF40 RPUSD3 SYNE2 MARK4 DIAPH2 EFR3B TAOK1 MAP2K3 UTRN AP3D1 IPO11	9.18e-07	1323	164	29	int:CDC42
Interaction	YWHAH interactions	ATG16L1 CDC42BPA UACA TRIO KIF26B MARK1 SPTAN1 CEP290 HJURP MPDZ ALS2 VPS13D CEP95 PI4KB SYNE2 MARK4 XRN1 MACF1 AKAP11 TAOK1 CRYBG3 HERC1 UTRN WDR62 CDK2	3.16e-06	1102	164	25	int:YWHAH
Interaction	GSK3B interactions	IPO5 RARS1 TRIO KIF26B ARHGEF12 MPDZ BIRC2 ZDBF2 RTN1 KHSRP VPS13D SYNE3 HP PHLPP1 MACF1 AKAP11 EIF3A CRYBG3 HSPA2 UTRN WDR62	8.01e-06	868	164	21	int:GSK3B
Interaction	DYRK1B interactions	TRRAP ARHGEF40 SERPINE1 AKAP11 MED23 MAP2K3 CDK2	9.48e-06	91	164	7	int:DYRK1B
Interaction	C11orf52 interactions	RAB23 ATP7A CDC42BPA UACA TRIO NOC2L MARK1 SPTAN1 MPDZ EFR3B MACF1 UTRN	9.55e-06	311	164	12	int:C11orf52
Interaction	GJA1 interactions	RAB23 ATG16L1 ATP7A CDC42BPA UACA TRIO VEZT MARK1 SPTAN1 SCYL3 UBQLN4 ITPR3 SYNE2 EFR3B MACF1 UTRN	2.31e-05	583	164	16	int:GJA1
Interaction	YWHAZ interactions	ATG16L1 CDC42BPA UACA KIF26B MARK1 SPTAN1 HJURP KCNAB2 ALS2 GCKR CUL7 ECHS1 VPS13D CEP95 UCHL5 NBEAL2 PI4KB SYNE2 MARK4 MACF1 AKAP11 EIF3A MAP2K3 HSPA2 WDR62 CDK2	2.37e-05	1319	164	26	int:YWHAZ
Interaction	GSK3A interactions	TRIO KIF26B ARHGEF12 MPDZ ZDBF2 RTN1 VPS13D MACF1 AKAP11 EIF3A CRYBG3 UTRN AP3D1 WDR62	2.75e-05	464	164	14	int:GSK3A
Interaction	BTN3A1 interactions	UACA VEZT TAOK3 TAOK1	3.32e-05	23	164	4	int:BTN3A1
GeneFamily	Cyclin dependent kinases	CDK19 CDKL4 CDK10 CDK2	1.94e-05	26	113	4	496
GeneFamily	ATPase copper transporting	ATP7A ATP7B	3.87e-05	2	113	2	1212
GeneFamily	Cyclins\|Mediator complex	CDK19 MED14 MED28 MED23	5.15e-05	33	113	4	1061
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE3 SYNE2	2.30e-04	4	113	2	1252
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	TAOK2 TAOK3 TAOK1	4.37e-04	24	113	3	654
GeneFamily	Glypicans	GPC3 GPC5	5.71e-04	6	113	2	572
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF12 ALS2 ARHGEF40	7.74e-04	66	113	4	722
GeneFamily	Cytochrome P450 family 3	CYP3A7 CYP3A5	1.06e-03	8	113	2	1002
GeneFamily	Myosins, class I	MYO1H MYO1F	1.06e-03	8	113	2	1097
GeneFamily	AT-rich interaction domain containing	ARID4B ARID5B	3.85e-03	15	113	2	418
GeneFamily	Dyneins, axonemal	DNAH10 DNAH17	4.95e-03	17	113	2	536
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD UTRN	5.55e-03	18	113	2	91
GeneFamily	Armadillo repeat containing\|Importins	IPO5 IPO11	5.55e-03	18	113	2	596
GeneFamily	Aminoacyl tRNA synthetases, Class I	RARS1 IARS1	6.18e-03	19	113	2	131
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS1 ADAMTS14	6.18e-03	19	113	2	50
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MOK TCF12 CDC42BPA TRIO CDK19 NEK7 TRRAP ADGRG6 TDRD7 TAOK3 SYNE2 ARID5B SERPINE1 PHLPP1 MACF1 AKAP11 EIF3A CRYBG3 DMD	2.47e-06	856	167	19	M4500
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	UACA TRIO SPTAN1 ARHGEF12 MPDZ GALNT18 TAOK2 HMCN1 SYNE2 DIAPH2 MACF1 UTRN	1.53e-11	200	167	12	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MOK KIF6 DNAH10 RGS22 CEP290 MPDZ SYNE2 DMD SPAG17 HYDIN	4.01e-09	197	167	10	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 MYO7B KIF26B RGS22 TRDN HMCN1 DMD SPAG17 HYDIN	3.38e-08	184	167	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 MYO7B KIF26B RGS22 TRDN HMCN1 DMD SPAG17 HYDIN	3.38e-08	184	167	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 MYO7B KIF26B RGS22 TRDN HMCN1 DMD SPAG17 HYDIN	3.38e-08	184	167	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOK DNAH10 RGS22 CDKL4 ZDBF2 ZNF446 METTL15 FHIP1A HYDIN	3.54e-08	185	167	9	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MPP3 CDC42BPA UACA CYP3A5 CRPPA RTN1 GALNT18 SERPINE1 NOVA2	4.25e-08	189	167	9	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	CDC42BPA UACA CYP3A5 ARHGEF12 CRPPA RTN1 GALNT18 SYNE2 SERPINE1	5.81e-08	196	167	9	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B ZDBF2 SYNE2 ARID5B XRN1 MACF1 HERC1 MED23 UTRN	6.07e-08	197	167	9	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	UACA SPTAN1 ARHGEF12 GALNT18 TAOK2 SYNE2 DIAPH2 MACF1 UTRN	6.91e-08	200	167	9	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RARS1 UACA CRPPA ZDBF2 TDRD7 HMCN1 XRN1 INTS9	5.75e-07	188	167	8	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RARS1 UACA CRPPA ZDBF2 TDRD7 HMCN1 XRN1 INTS9	5.75e-07	188	167	8	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RARS1 UACA CRPPA ZDBF2 TDRD7 HMCN1 XRN1 INTS9	5.75e-07	188	167	8	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	WWC3 UACA CYP3A5 ARHGEF12 RTN1 GALNT18 SYNE2 SERPINE1	7.88e-07	196	167	8	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP3A5 ANO1 LRRN3 GPC3 HMCN1 ABCA6 SERPINE1 MACF1	8.83e-07	199	167	8	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CDC42BPA ARID4B UACA CEP290 VPS13D SYNE2 SPAG17 AP3D1	8.83e-07	199	167	8	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP3A5 ANO1 LRRN3 GPC3 HMCN1 ABCA6 SERPINE1 MACF1	8.83e-07	199	167	8	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP3A5 ANO1 LRRN3 GPC3 HMCN1 ABCA6 SERPINE1 MACF1	8.83e-07	199	167	8	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	UACA CYP3A5 SPTAN1 ADGRG6 VPS13D CEP95 MED23 UTP14C	8.83e-07	199	167	8	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 XRN1 MACF1	9.17e-07	200	167	8	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	UACA ADAMTS1 ANO1 LRRN3 GPC3 HMCN1 ABCA6 MACF1	9.17e-07	200	167	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	WWC3 UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 XRN1	9.17e-07	200	167	8	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	UACA SPTAN1 ARHGEF12 MPDZ GALNT18 TAOK2 DIAPH2 MACF1	9.17e-07	200	167	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	UACA ADAMTS1 ANO1 LRRN3 GPC3 HMCN1 ABCA6 MACF1	9.17e-07	200	167	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UACA ADAMTS1 ANO1 LRRN3 GPC3 HMCN1 ABCA6 MACF1	9.17e-07	200	167	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CYP3A5 ARHGEF12 RTN1 GALNT18 SYNE2 SERPINE1 NOVA2	5.59e-06	181	167	7	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	MPP3 CYP3A5 ARHGEF12 CRPPA GALNT18 SERPINE1 NOVA2	6.45e-06	185	167	7	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	UACA ANO1 GPC3 HMCN1 ABCA6 MACF1 CAB39L	6.92e-06	187	167	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MPP3 GALNT18 NRBP2 NBEAL2 EFR3B GPC5 FHIP1A	6.92e-06	187	167	7	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	MPP3 CYP3A5 ARHGEF12 CRPPA GALNT18 SERPINE1 NOVA2	6.92e-06	187	167	7	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	DNAH10 RGS22 CEP290 PRR18 SPAG17 HSPA2 HYDIN	7.17e-06	188	167	7	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	UACA CARHSP1 CYP3A5 CRPPA RTN1 GALNT18 NOVA2	7.17e-06	188	167	7	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GALNT18 ST14 ADGRG6 NBEAL2 GPC5 LONRF2 FHIP1A	7.17e-06	188	167	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	COVID-19_Mild-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CYP3A5 CCDC168 CHD5 RASL11B GPAT2 NOVA2	7.43e-06	124	167	6	5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	RAB23 CARHSP1 UCHL5 GPAT2 RAD54L WDR62 CDK2	7.68e-06	190	167	7	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WWC3 UACA CYP3A5 GALNT18 SERPINE1 PHLPP1 NOVA2	7.68e-06	190	167	7	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UACA ANO1 GPC3 HMCN1 ABCA6 MACF1 CAB39L	7.95e-06	191	167	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UACA ANO1 GPC3 HMCN1 ABCA6 MACF1 CAB39L	8.22e-06	192	167	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	UACA KIF26B ANO1 LRRN3 GPC3 HMCN1 MACF1	8.22e-06	192	167	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	MOK KIF6 DNAH10 RGS22 DMD SPAG17 HYDIN	8.50e-06	193	167	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH10 ARHGEF12 MPDZ GALNT18 SYNE2 SPAG17 HYDIN	9.09e-06	195	167	7	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH10 ARHGEF12 MPDZ GALNT18 SYNE2 SPAG17 HYDIN	9.09e-06	195	167	7	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGEF12 MPDZ GALNT18 SYNE2 MACF1 SPAG17 HYDIN	9.40e-06	196	167	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGEF12 MPDZ GALNT18 SYNE2 MACF1 SPAG17 HYDIN	9.40e-06	196	167	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	UACA ANO1 LRRN3 GPC3 HMCN1 ABCA6 MACF1	9.72e-06	197	167	7	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CYP3A7 CARHSP1 CYP3A5 GPC3 ABCA6 MACF1 HSPA2	9.72e-06	197	167	7	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	tumor_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	ADAMTS1 MARK1 GALNT18 ITIH3 ADGRG6 RASL11B DMD	1.00e-05	198	167	7	f540f464118edc0fb809ebcb813d0302e6952253
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	UACA ANO1 LRRN3 MLH3 GPC3 HMCN1 MACF1	1.00e-05	198	167	7	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	PSB\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	UACA DNAH10 RGS22 NUCB2 MPDZ DMD SPAG17	1.00e-05	198	167	7	4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626
ToppCell	distal-mesenchymal-Alveolar_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 ANO1 GPC3 HMCN1 ABCA6 MACF1 CAB39L	1.04e-05	199	167	7	28c1722deef3b8347371c7359be7c64b95780de3
ToppCell	lymphoid-NK_cell-NK_cell\|NK_cell / Lineage, cell class and subclass	ARID4B BIRC2 GSAP SYNE2 MYO1F XRN1 MAP2K3	1.04e-05	199	167	7	945fbf5845403a8b22d04963f50ad69c414b6153
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS1 ANO1 LRRN3 GPC3 HMCN1 ABCA6 MACF1	1.04e-05	199	167	7	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 MACF1	1.07e-05	200	167	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 KIF26B ADH4 GPC3 ABCA6 ARID5B MACF1	1.07e-05	200	167	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 GPC3 HMCN1 ABCA6 ARID5B MACF1 CAB39L	1.07e-05	200	167	7	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 MACF1	1.07e-05	200	167	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 MACF1	1.07e-05	200	167	7	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 GPC3 HMCN1 ABCA6 ARID5B MACF1 CAB39L	1.07e-05	200	167	7	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 ANO1 ITIH3 GPC3 ABCA6 ARID5B CAB39L	1.07e-05	200	167	7	750ff51c9de08aecec230f4a402e0bf5a789f24c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 MACF1	1.07e-05	200	167	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 GPC3 HMCN1 ABCA6 ARID5B MACF1 CAB39L	1.07e-05	200	167	7	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 ANO1 CRPPA ADGRG6 DIAPH2 DMD LONRF2	1.07e-05	200	167	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	UACA CARHSP1 SPTAN1 ARHGEF12 GALNT18 SYNE2 MACF1	1.07e-05	200	167	7	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	COVID-19_Moderate-multiplets\|COVID-19_Moderate / disease group, cell group and cell class	GCKR ADGRG6 NBEAL2 SYNE2 MYO1F MACF1	1.96e-05	147	167	6	baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D175\|Adult / Lineage, Cell type, age group and donor	RAB23 MYO1H ANO1 ISOC2 STAG3 CDK2	3.27e-05	161	167	6	048b7dc00746987a24bf870d4d278c4183eb04a2
ToppCell	droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BIRC2 GALNT18 TAOK2 NBEAL2 FHIP1A NOVA2	4.15e-05	168	167	6	2201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF26B ALS2 RPUSD3 METTL15 FHIP1A CDK2	4.15e-05	168	167	6	c7021748003e5949f7caf7b3291c5bad294948c1
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TDRD5 DNAH10 RGS22 DMD SPAG17 HYDIN	4.29e-05	169	167	6	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MPP3 CYP3A7 CYP3A5 SERPINE1 DMRTA1 ADAMTS14	4.29e-05	169	167	6	225aec04ba762d4c55885257de03a65b63503fbb
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MPP3 CYP3A7 CYP3A5 SERPINE1 DMRTA1 ADAMTS14	4.29e-05	169	167	6	278960f940b646a788360b1c84d641a8d169896b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	UACA ADAMTS1 ANO1 HMCN1 MACF1 DMD	5.21e-05	175	167	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS1 MARK1 ANO1 ITIH3 DMD GPAT2	5.21e-05	175	167	6	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B NUP210L SYNE2 XRN1 DIAPH2 UTRN	5.73e-05	178	167	6	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF6 DNAH10 RGS22 CDKL4 SPAG17 HYDIN	5.73e-05	178	167	6	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF6 DNAH10 RGS22 CDKL4 SPAG17 HYDIN	5.73e-05	178	167	6	579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCell	RSV-Healthy-0\|RSV / Virus stimulation, Condition and Cluster	CRPPA BRPF1 SYNE2 PHLPP1 UTRN STAG3	6.09e-05	180	167	6	974044056e2f7e909cb11c6f6ca89e58bf95f7e5
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	MPP3 CYP3A5 CRPPA GALNT18 SERPINE1 NOVA2	6.09e-05	180	167	6	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MPP3 CYP3A7 CYP3A5 GALNT18 SERPINE1 NOVA2	6.09e-05	180	167	6	162cec1734e560c068cd61717e40e18dcf92308c
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	MPP3 CYP3A7 CYP3A5 GALNT18 SERPINE1 NOVA2	6.09e-05	180	167	6	33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd
ToppCell	RSV-Healthy-0\|Healthy / Virus stimulation, Condition and Cluster	CRPPA BRPF1 SYNE2 PHLPP1 UTRN STAG3	6.09e-05	180	167	6	703a1d0f9536af94d56757eb01221878d7b7fe61
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MOK KIF6 DNAH10 RGS22 SPAG17 HYDIN	6.28e-05	181	167	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UACA CYP3A5 LRRN3 GPC3 HMCN1 ABCA6	6.28e-05	181	167	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	KIF6 DNAH10 RGS22 PRR18 SPAG17 HYDIN	6.48e-05	182	167	6	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	UACA CYP3A5 CRPPA RTN1 GALNT18 NOVA2	6.48e-05	182	167	6	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GSAP ST14 TDRD7 GPC5 DMD FHIP1A	6.68e-05	183	167	6	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ARID4B TRIO SYNE2 XRN1 TAOK1 UTRN	6.68e-05	183	167	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	facs-Lung-EPCAM-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOK KIF6 DNAH10 RGS22 SPAG17 HYDIN	6.88e-05	184	167	6	afb11ab301ef9801333dbb53ccff4bd0d44f1677
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	RGS22 MPDZ HMCN1 ABCA6 CRYBG3 UTRN	6.88e-05	184	167	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Lung-EPCAM-24m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOK KIF6 DNAH10 RGS22 SPAG17 HYDIN	6.88e-05	184	167	6	a411c0bcb283534a1c15f22473c46b7d87e01294
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	DNAH10 ADAMTS1 CDKL4 SYNE2 MYO1F MACF1	6.88e-05	184	167	6	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UACA LRRC70 GALNT18 DMRTA1 UTRN IPO11	7.09e-05	185	167	6	a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	MOK KIF6 DNAH10 RGS22 SPAG17 HYDIN	7.09e-05	185	167	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	MOK KIF6 DNAH10 RGS22 SPAG17 HYDIN	7.09e-05	185	167	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MOK DNAH10 RGS22 MPDZ SPAG17 HYDIN	7.30e-05	186	167	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARID4B MED14 ARHGEF12 VPS13D HMCN1 DCAF17	7.30e-05	186	167	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MOK DNAH10 CDKL4 PRR18 SPAG17 HYDIN	7.52e-05	187	167	6	1bba994aaaa9825b54aaeaff3829850267bc4602
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	UACA MARK1 HMCN1 ABCA6 CAB39L DMD	7.52e-05	187	167	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MOK DNAH10 CDKL4 PRR18 SPAG17 HYDIN	7.52e-05	187	167	6	d6ac351e7aeba98851d308c14ac395044fe4fbbb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 RGS22 CRPPA ADGRG6 DMD LONRF2	7.75e-05	188	167	6	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARID4B SYNE2 MACF1 TAOK1 HERC1 UTRN	7.75e-05	188	167	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	MPP3 CDK19 MED14 GSAP TRRAP VPS13D SYNE2 MACF1 AKAP11 EIF3A HERC1	1.55e-07	191	165	11	4168_DN
Drug	Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	IPO5 HDAC11 CYP3A5 SPTAN1 MED14 ARHGEF12 KHSRP TAOK2 MARK4 HSPA2	1.75e-06	196	165	10	4122_DN
Drug	plakin	SPTAN1 NAA50 SYNE3 SYNE2 MACF1 DMD UTRN	2.23e-06	82	165	7	CID000018752
Drug	liarozole	ATP7A RARS1 CYP3A5 CYP19A1 IVL	8.87e-06	39	165	5	CID000060652
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A	TRIO ADAMTS1 GSAP CUL7 TRRAP ST14 ITPR3 TAOK2 SERPINE1	1.11e-05	191	165	9	4647_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A	HDAC11 ATG16L1 TRIO VEZT CYP3A5 ITIH3 LRRN3 RASL11B CA5B	1.31e-05	195	165	9	4016_UP
Drug	nocodazole; Down 200; 1uM; MCF7; HG-U133A	IPO5 CDK19 ARHGEF12 KHSRP ITPR3 TAOK2 VPS13D MARK4 EIF3A	1.48e-05	198	165	9	621_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	RAB23 ATG16L1 RARS1 SPTAN1 CDK19 ARHGEF12 MINPP1 PI4KB MARK4	1.48e-05	198	165	9	1868_DN
Drug	Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	IPO5 HDAC11 CDC42BPA CYP3A5 ARHGEF12 MPDZ CUL7 ZNF446 MARK4	1.48e-05	198	165	9	1489_UP
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	RARS1 SPTAN1 ARHGEF12 GSAP CUL7 MARK4 UTRN RAD54L WDR62	1.54e-05	199	165	9	1804_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A	HDAC11 ATG16L1 VEZT SPTAN1 ITPR3 TAOK2 MARK4 UTRN NOVA2	1.60e-05	200	165	9	2633_UP
Disease	occipital horn syndrome (implicated_via_orthology)	ATP7A ATP7B	2.92e-05	2	160	2	DOID:0111272 (implicated_via_orthology)
Disease	idiopathic scoliosis (implicated_via_orthology)	KIF6 DNAH10 ADGRG6	8.32e-05	16	160	3	DOID:0060250 (implicated_via_orthology)
Disease	central nervous system disease (implicated_via_orthology)	TAOK2 TAOK3 TAOK1	8.32e-05	16	160	3	DOID:331 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	MPP3 DNAH10 CRPPA GCKR ABCA6 SYNE2 MACF1 NOVA2	1.02e-04	264	160	8	EFO_0008317, EFO_0020944
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	DNAH10 MYO1H GCKR ABCA6 SYNE2 MACF1 MCUB	1.15e-04	200	160	7	EFO_0004611, EFO_0020945
Disease	overall survival, response to antineoplastic agent	UACA WDR62	1.74e-04	4	160	2	EFO_0000638, GO_0097327
Disease	tacrolimus measurement	CYP3A7 CYP3A5	1.74e-04	4	160	2	EFO_0008458
Disease	metal metabolism disorder (implicated_via_orthology)	ATP7A ATP7B	1.74e-04	4	160	2	DOID:896 (implicated_via_orthology)
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK1 MARK4	1.74e-04	4	160	2	DOID:0070356 (implicated_via_orthology)
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6 MCUB	1.80e-04	215	160	7	EFO_0008317, EFO_0008591
Disease	total blood protein measurement	RASA2 CYP19A1 ARHGEF12 CRPPA GCKR ABCA6 MARK4 ARID5B MACF1 HYDIN	1.80e-04	449	160	10	EFO_0004536
Disease	haptoglobin measurement	HP TLE7 HYDIN	1.94e-04	21	160	3	EFO_0004640
Disease	triglycerides in medium VLDL measurement	MPP3 DNAH10 GCKR ITIH3	2.29e-04	55	160	4	EFO_0022155
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6 NOVA2	2.31e-04	224	160	7	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6 NOVA2	2.37e-04	225	160	7	EFO_0008317, EFO_0010351
Disease	triglycerides in large VLDL measurement	MPP3 DNAH10 GCKR ITIH3	2.46e-04	56	160	4	EFO_0022178
Disease	Ovarian Serous Adenocarcinoma	MARK1 NEK7 TRRAP	2.56e-04	23	160	3	C1335177
Disease	Malignant neoplasm of breast	KIF6 ATP7B ADAMTS1 CYP19A1 SPTAN1 MED14 BIRC2 HP UNC45B MED28 CHD5 SYNE2 MACF1 DHX32 DMD RAD54L	2.56e-04	1074	160	16	C0006142
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6 MCUB	2.64e-04	229	160	7	EFO_0004639, EFO_0008317
Disease	Wilson disease (implicated_via_orthology)	ATP7A ATP7B	2.89e-04	5	160	2	DOID:893 (implicated_via_orthology)
Disease	aortic aneurysm (implicated_via_orthology)	ATP7A SERPINE1	2.89e-04	5	160	2	DOID:3627 (implicated_via_orthology)
Disease	Menkes disease (implicated_via_orthology)	ATP7A ATP7B	2.89e-04	5	160	2	DOID:1838 (implicated_via_orthology)
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	MPP3 DNAH10 MYO1H TMPRSS11E GCKR SYNE2	3.01e-04	166	160	6	EFO_0004530, EFO_0004611
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	MPP3 DNAH10 MYO1H TMPRSS11E GCKR ADH4 ABCA6 MCUB	3.39e-04	315	160	8	EFO_0004612, EFO_0008591
Disease	Congenital muscular dystrophy (disorder)	CRPPA SYNE2	4.32e-04	6	160	2	C0699743
Disease	glucagon measurement, glucose tolerance test	MACF1 HERC1	4.32e-04	6	160	2	EFO_0004307, EFO_0008463
Disease	Intravascular hemolysis	ATP7A HP	4.32e-04	6	160	2	C0235574
Disease	Hemolysis (disorder)	ATP7A HP	4.32e-04	6	160	2	C0019054
Disease	Extravascular Hemolysis	ATP7A HP	4.32e-04	6	160	2	C0312854
Disease	cholesterol in very large VLDL measurement	MPP3 DNAH10 GCKR ITIH3	4.36e-04	65	160	4	EFO_0022230
Disease	total lipids in large VLDL	MPP3 DNAH10 GCKR ITIH3	4.89e-04	67	160	4	EFO_0022175
Disease	breast size	MARK1 GCKR GPC5 SPAG17	5.47e-04	69	160	4	EFO_0004884
Disease	very low density lipoprotein cholesterol measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6 MYO1F	5.65e-04	260	160	7	EFO_0008317
Disease	Cerebral ventriculomegaly	CRPPA HYDIN	6.03e-04	7	160	2	C1531647
Disease	Hydrocephalus Ex-Vacuo	CRPPA HYDIN	6.03e-04	7	160	2	C0270720
Disease	Communicating Hydrocephalus	CRPPA HYDIN	6.03e-04	7	160	2	C0009451
Disease	Fetal Cerebral Ventriculomegaly	CRPPA HYDIN	6.03e-04	7	160	2	C2936718
Disease	Post-Traumatic Hydrocephalus	CRPPA HYDIN	6.03e-04	7	160	2	C0477432
Disease	Obstructive Hydrocephalus	CRPPA HYDIN	6.03e-04	7	160	2	C0549423
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	GCKR ABCA6 SYNE2 MACF1 NOVA2	6.58e-04	127	160	5	EFO_0008595, EFO_0020947
Disease	serum metabolite measurement	CYP3A7 CDC42BPA TRIO CYP3A5 KIF26B TMPRSS11E GCKR CCNYL3 ECHS1 CDK10 ADH4 DNAH17 SYNE2 ARID5B	6.63e-04	945	160	14	EFO_0005653
Disease	follicle stimulating hormone measurement	CYP19A1 DRAM2 SYNE3	7.58e-04	33	160	3	EFO_0004768
Disease	Congenital Hydrocephalus	CRPPA HYDIN	8.01e-04	8	160	2	C0020256
Disease	Alcohol withdrawal syndrome	CYP19A1 MPDZ	8.01e-04	8	160	2	C0236663
Disease	Aqueductal Stenosis	CRPPA HYDIN	8.01e-04	8	160	2	C2936786
Disease	Todd Paralysis	ATP7A UNC45B	1.03e-03	9	160	2	C0234544
Disease	Paralysed	ATP7A UNC45B	1.03e-03	9	160	2	C0522224
Disease	Hydrocephalus	CRPPA HYDIN	1.03e-03	9	160	2	C0020255
Disease	spinal muscular atrophy (implicated_via_orthology)	ATP7A ATP7B	1.03e-03	9	160	2	DOID:12377 (implicated_via_orthology)
Disease	sexual dimorphism measurement	CDC42BPA RASA2 DNAH10 CYP19A1 ADGRG6 SEPTIN2 TAOK2 ARHGEF40 ZNF592 MYO1F EFR3B MACF1 HERC1 METTL15 AP3D1	1.04e-03	1106	160	15	EFO_0021796
Disease	waist-hip ratio	DNAH10 CYP19A1 ASB15 ZNF446 TAOK2 TDRD7 CAMKK2 DNAH17 SYNE2 ARID5B XRN1 EFR3B TAOK1 LONRF2 MAP2K3 AP3D1	1.06e-03	1226	160	16	EFO_0004343
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DNAH10 GCKR ABCA6 SYNE2 MACF1 MCUB NOVA2	1.09e-03	291	160	7	EFO_0008317, EFO_0020946
Disease	alcohol use disorder measurement	GCKR ADH4 PHLPP1 CAB39L METTL15 ARL14	1.14e-03	214	160	6	EFO_0009458
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	GCKR SYNE2 MACF1 MCUB NOVA2	1.16e-03	144	160	5	EFO_0004611, EFO_0020943
Disease	lipoprotein measurement, phospholipid measurement	MYO1H TMPRSS11E GCKR ABCA6	1.20e-03	85	160	4	EFO_0004639, EFO_0004732
Disease	dilated cardiomyopathy (is_marker_for)	TRDN HP DMD	1.24e-03	39	160	3	DOID:12930 (is_marker_for)
Disease	Seizures	ATP7A RARS1 MPDZ TRRAP MACF1 AP3D1	1.25e-03	218	160	6	C0036572
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	MPP3 DNAH10 TMPRSS11E GCKR ITIH3 ABCA6	1.31e-03	220	160	6	EFO_0004529, EFO_0008317
Disease	sleep apnea	KDM2B MACF1 METTL15	1.33e-03	40	160	3	EFO_0003877
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	MPP3 CRPPA GCKR ABCA6 SYNE2 MACF1	1.37e-03	222	160	6	EFO_0008317, EFO_0020943
Disease	neutrophil count	CDC42BPA RASA2 CYP3A5 NUP210L UBQLN4 NEK7 ARHGEF12 GCKR ADGRG6 IVL FAM228B SUPT5H NBEAL2 MARK4 AKAP11 AP3D1 HYDIN	1.41e-03	1382	160	17	EFO_0004833
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	MPP3 DNAH10 GCKR ITIH3 SYNE2 MACF1	1.44e-03	224	160	6	EFO_0004530, EFO_0008317
Disease	level of Ceramide (d40:1) in blood serum	GCKR SYNE2	1.56e-03	11	160	2	OBA_2045185
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	MPP3 RASA2 DNAH10 MYO1H GCKR ADH4 MCUB	1.72e-03	315	160	7	EFO_0004574, EFO_0004612
Disease	Adenocarcinoma of large intestine	TRRAP CAMKK2 MLH3 MARK4	1.88e-03	96	160	4	C1319315
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	CYP3A7 TMPRSS11E	2.19e-03	13	160	2	EFO_0800293
Disease	phosphoglycerides measurement	MYO1H TMPRSS11E GCKR	2.26e-03	48	160	3	EFO_0022291
Disease	Weight Gain	NEK7 ARHGEF12 VPS13D IPO11	2.34e-03	102	160	4	C0043094
Disease	hepatocellular carcinoma (implicated_via_orthology)	ATP7B UACA GPC3	2.40e-03	49	160	3	DOID:684 (implicated_via_orthology)
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GCKR SYNE2 MACF1 MCUB	2.43e-03	103	160	4	EFO_0008595, EFO_0020944
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	CYP3A7 TMPRSS11E	2.55e-03	14	160	2	EFO_0800283
Disease	body mass index, fasting blood glucose measurement	GCKR KDM2B DMRTA1	2.69e-03	51	160	3	EFO_0004340, EFO_0004465
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	DNAH10 MYO1H GCKR MCUB	2.69e-03	106	160	4	EFO_0008317, EFO_0008596
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	DNAH10 MYO1H GCKR MCUB	3.08e-03	110	160	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	Intellectual Disability	RARS1 TRIO TRRAP CDK10 MACF1 TAOK1 MED23 WDR62	3.15e-03	447	160	8	C3714756
Disease	Small cell carcinoma of lung	ZDBF2 KHSRP TAOK3	3.17e-03	54	160	3	C0149925
Disease	revision of total joint arthroplasty, aseptic loosening	CRPPA PHLPP1	3.34e-03	16	160	2	EFO_0010725, EFO_0020974
Disease	apolipoprotein B measurement	TCF12 DNAH10 TMPRSS11E GCKR ABCA6 SYNE2 MARK4 TAOK1 HYDIN NOVA2	3.44e-03	663	160	10	EFO_0004615
Disease	cholesteryl esters to total lipids in large VLDL percentage	MPP3 GCKR ABCA6	3.51e-03	56	160	3	EFO_0022250
Disease	alkaline phosphatase measurement	ATG16L1 NOC2L CYP19A1 TMPRSS11E NEK7 GCKR ITIH3 ADH4 SEPTIN2 ABCA6 MARK4 MACF1 UTRN	3.67e-03	1015	160	13	EFO_0004533
Disease	Sjogren's syndrome (implicated_via_orthology)	CYP19A1 ST14	3.77e-03	17	160	2	DOID:12894 (implicated_via_orthology)
Disease	protein C measurement	MYO7B GCKR	3.77e-03	17	160	2	EFO_0004633
Disease	free cholesterol to total lipids in very large VLDL percentage	MPP3 GCKR ABCA6	4.07e-03	59	160	3	EFO_0022289
Disease	chronic lymphocytic leukemia	SEPTIN2 PHLPP1 DMRTA1 METTL15	4.08e-03	119	160	4	EFO_0000095
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	CYP3A7 TMPRSS11E	4.22e-03	18	160	2	EFO_0800288
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	GCKR SYNE2 MACF1 MCUB	4.33e-03	121	160	4	EFO_0008595, EFO_0020943
Disease	disease progression measurement	ADGRG6 EIF3A HERC1	4.47e-03	61	160	3	EFO_0008336
Disease	BMI-adjusted waist circumference, physical activity measurement	DNAH10 NUCB2 ADGRG6 MYO1F	4.59e-03	123	160	4	EFO_0007789, EFO_0008002
Disease	phosphatidylcholine measurement	KIF6 MYO1H TMPRSS11E GCKR SYNE2 MACF1	4.65e-03	284	160	6	EFO_0010226
Disease	cleft lip	NUP210L CCDC168 CDK10 SEPTIN2 DMRTA1 GPC5	4.65e-03	284	160	6	EFO_0003959
Disease	phospholipids in large VLDL measurement	DNAH10 GCKR ITIH3	4.68e-03	62	160	3	EFO_0022169
Disease	metabolonic lactone sulfate measurement	CYP3A7 CYP3A5	4.70e-03	19	160	2	EFO_0800659
Disease	etiocholanolone glucuronide measurement	CYP3A7 TMPRSS11E	4.70e-03	19	160	2	EFO_0800362
Disease	triglyceride measurement, body mass index	DNAH10 GCKR	4.70e-03	19	160	2	EFO_0004340, EFO_0004530
Disease	oral squamous cell carcinoma (is_marker_for)	BIRC2 HP SERPINE1	4.90e-03	63	160	3	DOID:0050866 (is_marker_for)
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	GCKR ITIH3 ABCA6 NOVA2	4.99e-03	126	160	4	EFO_0004611, EFO_0010351
Disease	androsterone glucuronide measurement	CYP3A7 TMPRSS11E	5.21e-03	20	160	2	EFO_0800317
Disease	cholesterol in large VLDL measurement	DNAH10 GCKR ITIH3	5.34e-03	65	160	3	EFO_0021902

Protein segments in the cluster

Peptide	Gene	Start	Entry
LVNGTKVEVHKPEVL	TDRD5	801	Q8NAT2
HKNPAEIVKILKDNL	CAB39L	11	Q9H9S4
EENKVHADLVISKPV	ARID4B	761	Q4LE39
EITAKIQKLAHIPVQ	ERV3-1	586	Q14264
KEVEKVQLHSRFPQI	FAM228B	186	P0C875
IHVGPNQVKVLKLTE	DCAF17	356	Q5H9S7
IIKKQPVEVDHDQLE	CA5B	246	Q9Y2D0
PSIHIVNEVLKDILK	ERVK13-1	271	Q9NX77
KVENLQPEIKTIARH	COX18	111	Q8N8Q8
FLVPAKHLLAKVQQE	ARHGEF40	51	Q8TER5
RELKHPNVIALQKVF	CDK19	71	Q9BWU1
KPANAVLHKVLNQLE	CHD5	1851	Q8TDI0
NIGKHKVLPAVVDIE	CRYBG3	1856	Q68DQ2
KPQKVEHLAGRVVLQ	ALS2	191	Q96Q42
DLHKPIQEVIIELTK	ADH4	251	P08319
AEVLPSHKVAKVQEL	ATP7B	1241	P35670
LATHPDVQQKLQKEI	CYP3A5	321	P20815
VLAQKLQAEKHDVPN	ATG16L1	51	Q676U5
ILRHPEVKVQSKVAE	ADGRG6	421	Q86SQ4
KQLKHPNLVNLIEVF	CDKL4	56	Q5MAI5
NIKKSLQEHLPDVVV	HDAC11	241	Q96DB2
KLHEQLNVPVQKLTA	ABCA6	1401	Q8N139
KLVEAIKQGHIPELQ	ASB15	46	Q8WXK1
SVPQIHVNLDKKAVL	AKAP11	1636	Q9UKA4
EHIKNVPVVLLANKQ	ARL14	111	Q8N4G2
PDLEDLKRQVQQHKV	DMD	481	P11532
ALIQNLVKHLPEQKI	DIAPH2	746	O60879
LVKHLPEQKILNELA	DIAPH2	751	O60879
QQIVHLERDIKKFPQ	DIAPH2	921	O60879
NVPVIEVKNKHPVEV	DHX32	231	Q7L7V1
ALEKSPHRIVVKNQV	ADAMTS14	746	Q8WXS8
LKEIQEAKKHIPQLQ	ARHGEF12	236	Q9NZN5
HIQKLQAKDVPVAEE	AP3D1	581	O14617
EVLPSHKVAKVKQLQ	ATP7A	1276	Q04656
EKAFLEVNRPQIHKL	HJURP	356	Q8NCD3
QKLKQQIAEDPELTH	RAB23	171	Q9ULC3
IQQIKSIIEKLDEPH	RASA2	811	Q15283
QLKLDKEKLPVHVVV	RAD54L	131	Q92698
VVKILVIHDEQKGPE	ADAMTS1	306	Q9UHI8
QVSKLLKEVQPLHVV	INTS9	456	Q9NV88
QLQHLLKPVKRIQEE	ITPR3	2066	Q14573
QINSKLSKPEVVIIH	CRPPA	141	A4D126
QVHTALPKVNAKIVA	KIAA1107	391	Q9UPP5
KIQTVFEQLVLVDHP	NRBP2	86	Q9NSY0
ILPHQQVDKGAIKFV	MCTS1	91	Q9ULC4
ILPHQQVDKGAIKFV	MCTS2	91	A0A3B3IRV3
KIDHLKEQLQPLEQV	MCUB	191	Q9NWR8
GKKQLVEIEKVVLHP	HP	226	P00738
EPVVSQIIDKLKHIN	GPC3	456	P51654
IDPVINQIIDKLKHV	GPC5	451	P78333
VQVLKVVENALKVNP	IPO11	746	Q9UI26
AVIHDKLQVPNTIRK	KIF26B	161	Q2KJY2
QQVLILPKNFVIQHK	KIAA2026	1101	Q5HYC2
PIAQAKHAIQIKEKE	HERC1	1996	Q15751
DHLTQVKKPVIAAVN	ECHS1	121	P30084
EHKQKELERVCNPII	HSPA2	596	P54652
IELGDVTPHNIKQLK	NAA50	6	Q9GZZ1
RIEPADAHVLQKNLK	NAA50	141	Q9GZZ1
DAVHPQFKEIQKLIK	ISOC2	171	Q96AB3
IDHLEQEKQIKPNLT	MLH3	1406	Q9UHC1
KEIDLLKQLNHPNVI	NEK7	81	Q8TDX7
GNIKNAIKPVLIHLD	EFR3B	246	Q9Y2G0
IKKLDGPDHQEVLQI	CUL7	501	Q14999
KQVHALSPEENVIIK	DRAM2	76	Q6UX65
EKPQTKLLILHQAVA	TCF12	611	Q99081
KQHKQRCPVLEDQLV	MED23	291	Q9ULK4
KVTILEDPDQNIHLK	KIF6	171	Q6ZMV9
EPLLIKGHQVKAQAL	LONRF2	261	Q1L5Z9
QVLEDINVQHKKPAD	MED28	141	Q9H204
HRDVKPENILIKQDV	MOK	126	Q9UQ07
VIPDIPKDISQQIHK	ANO1	911	Q5XXA6
PSLKHIVENAVQKEL	IPO5	536	O00410
ELIHKKVLSPQDQDV	METTL15	376	A6NJ78
PIDIDKTKVQNIHPV	NUCB2	26	P80303
PEQVHKAVSAIVQKV	NOVA2	186	Q9UNW9
AKQRLTPKLFHEVVQ	NOC2L	161	Q9Y3T9
QREKVEVQLPELFHK	KCNAB2	221	Q13303
RLHKQIVPENEAQVI	LRRC70	601	Q7Z2Q7
LAEHQVPVEKLQKVA	MACF1	4051	Q9UPN3
HVPPVIKDKEQVTNV	HMCN1	1356	Q96RW7
DPITKIEKQATLHQL	MED14	181	O60244
VQVAHEKEQVIPIAL	GCKR	561	Q14397
EHFTQEQLKKVILPQ	SCYL3	366	Q8IZE3
LEVVKKDHVALQVPR	CBY2	226	Q8NA61
AEVLPQEIKQEIHQV	CCNYL3	246	P0C7X3
PDIHELVENIKSVLK	FAM189A2	351	Q15884
VEIHPVNNVKVLKAV	GSAP	131	A4D1B5
VVKILEKHDPLKNTQ	FHIP1A	36	Q05DH4
KEVKIEHQPVLRCQI	HYDIN	3126	Q4G0P3
PQALLEGVKNVLKEH	KDM2B	541	Q8NHM5
LIAKHPNVEEAIIKE	CYP19A1	321	P11511
IHEQLNRPKVNKIVE	DNAH17	241	Q9UFH2
AKALEVIKPAHILQE	EIF3A	531	Q14152
PNIVELKEVVVGNHL	CDK10	96	Q15131
DLEQQIKILKHVPEG	CEP290	2316	O15078
VVQAIEQVLNGKEHK	DMRTA1	356	Q5VZB9
VKKEVQRILGHIQAP	GPAT2	141	Q6NUI2
IAEPVRQKIAITHKN	MRPL58	111	Q14197
NVIKQHIQEAPAKPE	GALNT18	71	Q6P9A2
KVQENIGPLRIHEKE	CEP95	496	Q96GE4
HPNIVKLFEVIETEK	MARK1	116	Q9P0L2
KGLNHPNIVKLFEVI	MARK4	111	Q96L34
EIAILKKLDHPNVVK	CAMKK2	236	Q96RR4
KKLDHPNVVKLVEVL	CAMKK2	241	Q96RR4
EERKQEALLKVIPQH	CCDC168	1816	Q8NDH2
QIVSILIFPKHQEEK	CCDC168	5276	Q8NDH2
LATHPDVQQKVQKEI	CYP3A7	321	P24462
EISLLKELNHPNIVK	CDK2	51	P24941
KELNHPNIVKLLDVI	CDK2	56	P24941
PNIVKLLDVIHTENK	CDK2	61	P24941
IPAENIENVVKHVVL	DNAH10	2981	Q8IVF4
PEAVLVIQKRHLEKQ	PRR18	141	Q8N4B5
AKHADEKPINAIVIN	MDFIC2	36	A0A1B0GVS7
IQPIKFLIKHQQEVK	NUP210L	446	Q5VU65
EPLHVAQALQKVKIE	SERPINE1	336	P05121
ARLHELKQKVVAENP	MPP3	396	Q13368
VIHRDVKPSNVLINK	MAP2K3	186	P46734
PQQIDHAKQLIEEKI	KHSRP	481	Q92945
KLEHIDGVNLTVPVK	RPUSD3	191	Q6P087
HINAVVAKIQAKIPG	RTN1	756	Q16799
PVVVVANKADLLHIK	RASL11B	146	Q9BPW5
ANKADLLHIKQVDPQ	RASL11B	151	Q9BPW5
KVNPREIAENITKHL	RARS1	131	P54136
QLDKLGEQIAVIHEK	UTRN	1916	P46939
EVTKTQLEQLPEHIK	MRPS10	171	P82664
ENHVNDIKKPFVIKE	SYNE2	1181	Q8WXH0
QAQLKELIVFPHNLK	SYNE3	396	Q6ZMZ3
NRLIKVPHVALQKVV	LRRN3	246	Q9H3W5
VPHVALQKVVNLKFL	LRRN3	251	Q9H3W5
LDAPVLVEIQKHVQN	RGS22	946	Q8NE09
IPVEQAQKIIEHRKE	RGS22	1096	Q8NE09
NKHLDVEKIVNLFPQ	SCRN3	391	Q0VDG4
KEKVIPDEVHQNQIL	FAM183A	6	A6NL82
LKVQPKQLVKHFEIE	ITIH3	171	Q06033
IGVVNPKHAQLVREK	NBEAL2	2126	Q6ZNJ1
LGVHEQKQQVVKFLI	POTEJ	241	P0CG39
PIVHINKTLEEINQE	SHOC1	561	Q5VXU9
EVKFLQRIKHPNSIE	TAOK1	76	Q7L7X3
LEVHKKPLQEVEIAA	TAOK1	116	Q7L7X3
LEVHKKPLQEVEIAA	TAOK2	116	Q9UL54
LLEVHKKPLQEVEIA	TAOK3	111	Q9H2K8
QLEVTPKNEHKTILK	TAOK3	741	Q9H2K8
VVIHQDPEALKDIKS	IARS1	851	P41252
QNNIHVKDIVKVIDG	SUPT5H	591	O00267
KHELVNIRKVQPLVD	TDRD7	996	Q8NHU6
RNHVEKKPLVALVQT	TDRD7	1041	Q8NHU6
KHLEKQEAQLELPEQ	IVL	481	P07476
EPVVNAVSIHQVKKQ	PI4KB	611	Q9UBF8
KKIHQIELIPNDQLV	CDC42BPA	1266	Q5VT25
PHLLVNIEKQKLELE	MSANTD4	201	Q8NCY6
EHFKPKVLLQVLQEA	SPAG17	786	Q6Q759
LVLLENQKHLPVEEQ	BRPF1	771	P55201
NQKHLPVEEQLKLLL	BRPF1	776	P55201
QEHDIIKQKTQIPLQ	BIRC2	491	Q13490
DDIHNALKQTPKVLV	ARID5B	636	Q14865
PKNEKLQAVEVVITH	CARHSP1	116	Q9Y2V2
PETVDKIVQLVLHEK	TMPRSS11E	131	Q9UL52
KTLAEHQQLIPLVEK	UCHL5	301	Q9Y5K5
HQQLIPLVEKAKEKQ	UCHL5	306	Q9Y5K5
VIPELVQLAKFSKQH	UNC45B	591	Q8IWX7
KNLPNVIISEKRNIH	UTP14C	661	Q5TAP6
NHQDVVNILKELPIE	MPDZ	611	O75970
HLDKAVEQKQRSQPI	MINPP1	346	Q9UNW1
LQQLQEVVVKHAEPA	STAG3	626	Q9UJ98
IQEQHPEEELIKTKQ	SPTAN1	216	Q13813
VHQVKKAAPLIVEVF	ZNF592	541	Q92610
KAAPLIVEVFNKVLH	ZNF592	546	Q92610
VEFLPVNNVKKVEKH	ST14	36	Q9Y5Y6
DLQNQILIRKHEVPV	TLE7	276	A0A1W2PR48
VDHKNEIKQIANEIP	XRN1	1371	Q8IZH2
LEKGQQQPLEFVHKI	ZDBF2	141	Q9HCK1
VNLPKEVHIGLVDKN	ZDBF2	516	Q9HCK1
VKKLNPQKEEQVHLE	ZDBF2	891	Q9HCK1
SVADQPKVAIKHVNL	ZDBF2	1126	Q9HCK1
ENDIFEINLPKHVIK	ZNF780B	91	Q9Y6R6
TAHVLKQEVLPAAQK	ZNF446	116	Q9NWS9
LENVKAKLAQHVKPE	UACA	671	Q9BZF9
HVPLEQVEALKKSLN	UACA	1111	Q9BZF9
CVVVILDPKENKQQH	WDR62	91	O43379
HVNAVFQKTIEPLLK	TOPAZ1	411	Q8N9V7
KPAISEKVQIHKQDI	TRDN	531	Q13061
EKEKQQHLLQVPAEA	PHLPP1	1576	O60346
IHNKVNIVPVIAKAD	SEPTIN2	171	Q15019
LEQKLKLIQPHVQAS	VEZT	471	Q9HBM0
LTVHLVIKTPQKAQD	UBQLN4	76	Q9NRR5
DELKAKVLQHILNPA	TRRAP	1766	Q9Y4A5
HKEPIQVQTFREKIA	WWC3	1061	Q9ULE0
HIKAPEQQVKNILNE	TRIO	1101	O75962
EGKFVNPVQVVLAKH	VPS13D	1526	Q5THJ4
KVQHVKDIILQSNPL	MYO1F	136	O00160
INPKVLQLISHEKIQ	MYO1H	876	Q8N1T3
LELQAVKSKKHIPIQ	MYO7B	1186	Q6PIF6